Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01038076 · ClinicalTrials.gov registry record · NA
Medications for Chronic HIV: Education and Collaboration
A NA study of HIV Infections and Medication Adherence, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 371
- Enrollment target
- 3
- Study locations
NCT01038076: Completed NA study of HIV Infections and Medication Adherence, sponsored by Boston University.
NCT01038076 is a NA study of HIV Infections and Medication Adherence that has completed, run by Boston University. The registered enrollment target is 371 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (17% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01038076, a NA study of HIV Infections and Medication Adherence, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 371 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will examine whether a computerized, self-administered assessment of patient medication adherence and health behaviors, plus support for adherence, improves the ability of clinicians to identify adherence problems and leads to better adherence.
Conditions Studied
Interventions
- BEHAVIORAL MedCHEC Tablet Computer & Adherence Care
Study Locations (3)
Massachusetts
- VA Boston - Boston
- Boston Medical Center - Boston
California
- VA Greater Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2009-12 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT01038076 record still lists
NCT01038076 is an interventional study that assigns participants to a tested intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (17% lower).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which MedCHEC Tablet Computer & Adherence Care is the first listed.
NCT01038076 reports a single indexed study location in Massachusetts, California.
Frequently Asked Questions
What is clinical trial NCT01038076 about?
NCT01038076 is a clinical study titled "Medications for Chronic HIV: Education and Collaboration". This study will examine whether a computerized, self-administered assessment of patient medication adherence and health behaviors, plus support for adherence, improves the ability of clinicians to identify adherence problems and leads to better adherence.
What is the current status of trial NCT01038076?
This trial is currently completed. It is a NA study. The enrollment target is 371 participants. The study started on 2009-12. Estimated completion is 2017-12.
What conditions does trial NCT01038076 study?
This clinical trial studies the following conditions: HIV Infections, Medication Adherence, Acquired Immunodeficiency Syndrome.
What interventions are being tested in trial NCT01038076?
The interventions under investigation include: MedCHEC Tablet Computer & Adherence Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT01038076?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01038076 being conducted?
This trial has 3 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01038076's enrollment target sits among peer trials
371 90th of 542 higher than 452 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia